IOL Chemicals and Pharmaceuticals Limited — Updates, 27-10-2025: General Updates
27-10-2025 | 05:46 pm
27-10-2025 | 05:46 pm
IOL Chemicals & Pharmaceuticals received EDQM's Certificate of Suitability (CEP) for Sitagliptin Phosphate Monohydrate. This API, an oral antidiabetic medication, enhances its market prospects in Europe.
No comments yet. Be the first to comment!
All announcements from IOL Chemicals and Pharmaceuticals Limited
